eMedCodes logo

COMBIVIR - lamivudine and zidovudine

Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC
Field Value
NDC Code: 0173-0595
Proprietary Name: COMBIVIR
Suffix:
Non-Proprietary Name: lamivudine and zidovudine
Dosage Form: TABLET, FILM COATED
Method: ORAL
Original Marketing Date: 30-09-1997
End of Marketing: 31-07-2014
Category Name: NDA
Application Number: NDA020857
Labeler: GLAXOSMITHKLINE LLC
Substance Name: LAMIVUDINE; ZIDOVUDINE
Active Numerator Strength: 150; 300
Active Ingredient Unit: mg/1; mg/1
Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
DEA Schedule: